Quantcast

Latest Valvular heart disease Stories

heart
2014-08-14 02:00:48

DETROIT, Aug. 13, 2014 /PRNewswire/ -- For the first time in the United States, doctors at Henry Ford Hospital used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one - and placed it just outside the heart. Due to prior medical procedures, the metro Detroit woman was not a candidate for traditional open heart surgery to replace her failing tricuspid valve. One major U.S. medical center turned her down for treatment. Doctors at another said her...

2014-08-12 12:27:43

- Medicare will Provide National Coverage for People with Severe Degenerative Mitral Regurgitation Deemed Too Sick for Surgery ABBOTT PARK, Ill., Aug. 12, 2014 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) recently issued a National Coverage Determination (NCD) that extends coverage for Medicare beneficiaries in the United States to Transcatheter Mitral Valve Repair with Abbott's (NYSE: ABT) MitraClip(® )System. The MitraClip System is a...

2014-08-07 23:11:05

HeartStitch, Inc. receives landmark patent "Suturing Devices and Methods for Suturing an Anatomic Valve" FOUNTAIN VALLEY, CA – (PRWEB) August 07, 2014 -- By: HeartStitch Prof. Anthony Nobles, CEO of HeartStitch HeartStitch, Inc. today announced that it has received another US Patent for its HeartStitch Technology. The patent “Suturing devices and methods for suturing an anatomic valve” is for the HeartStitch MR and AP products that are designed to allow physicians to be...

2014-08-07 16:27:55

Valve Clinic Team is first locally to use device for Mitral Valve Regurgitation CLEARWATER, Fla., Aug. 7, 2014 /PRNewswire-USNewswire/ -- Morton Plant Hospital continues to offer the latest treatments in cardiac care, particularly for individuals with heart valve problems who may not be able to have traditional open heart surgery. Morton Plant is among the first hospitals in Florida and the first locally to use the new MitraClip device for people with severe mitral valve regurgitation....

2014-07-31 17:32:49

Oxford University Press Data taken from the German Aortic Valve Registry and published in the European Journal of Cardio-Thoracic Surgery A survey, published online in the European Journal of Cardio-Thoracic Surgery, of 13,860 patients who had undergone interventions for aortic valve disease in Germany has revealed that over 80% were in the same or a better state of health one year after the intervention, and was satisfied with the procedural outcome. Aortic stenosis – the...

2014-07-29 23:04:40

Global Cardiac Surgery devices market growth will be driven by extensive technological advancements, especially for transcatheter heart valve devices, reports iData Research Vancouver, BC (PRWEB) July 29, 2014 According to a new report series by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the Global Cardiac Surgery Devices Market will grow to over $8 billion by 2018. This growth will be fueled by extensive technological...

2014-07-14 23:02:06

Comprehensive study “European Market for Cardiac Surgery Devices 2014” worked out by iData Research is now available at MarketPublishers.com. According to the report, Europe’s market for cardiac surgery devices is projected to grow to over USD 3.4 billion by 2020. London, UK (PRWEB) July 14, 2014 Europe’s market for cardiac surgery devices is projected to grow to over USD 3.4 billion by 2020, with the transcatheter heart valve devices sector (composed of the transcatheter heart...

2014-07-14 20:21:24

European Launch Means Physicians Can Now Choose From Three Available Valve Sizes To Match Patient Anatomy More Precisely MARLBOROUGH, Mass., July 14, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European commercial launch of its new 25 mm Lotus(TM) Transcatheter Aortic Valve Implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes. "Having the 25 mm size allows us to be more precise in selecting the...

2014-07-03 23:03:47

GIA announces the release of a comprehensive global report on Prosthetic Heart Valves. Global market for Prosthetic Heart Valves is projected to reach US$4.8 billion by 2020, driven by aging population & increasing prevalence of cardiovascular disorders, growing adoption of bioprosthetic/tissue heart valves, and regulatory clearance of Transcatheter Aortic Valve Implantation (TAVI) in major markets. San Jose, California (PRWEB) July 03, 2014 Follow us on LinkedIn. – Prosthetic heart...

2014-06-16 20:21:59

FDA Approval Includes High-Risk and Inoperable Indications, Transfemoral and Alternative Access Systems IRVINE, Calif., June 16, 2014 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has received United States Food and Drug Administration (FDA) approval for its Edwards SAPIEN XT transcatheter aortic heart valve for the treatment of high-risk and inoperable patients...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related